Defining and Measuring the Affordability of New Medicines: A Systematic Review
Crossref DOI link: https://doi.org/10.1007/s40273-017-0514-4
Published Online: 2017-05-05
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
AntoƱanzas, Fernando http://orcid.org/0000-0001-6122-9130
Terkola, Robert
Overton, Paul M.
Shalet, Natalie
Postma, Maarten
Funding for this research was provided by:
Novartis Pharma (Agora Think Tank)
License valid from 2017-05-05